Therapeutic/cosmetic compositions comprising CGRP antagonists for treating skin redness/rosacea/discreet erythema
US6509014B1 · kind B1 · utility
58Cited by
1References
48Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 25, 1999 |
| Grant date | Jan 21, 2003 |
| Priority date | — |
| Expiry date | May 25, 2019 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S424/809
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Skin redness, rosacea and/or discreet erythema afflicting a mammalian, notably human patient, are therapeutically treated by administrating to such patient a therapeutically/cosmetically effective amount of at least one CGRP antagonist, advantageously in combinatory immixture with at least one antagonist of a neuropeptide other than CGRP, e.g., a substance P antagonist, and/or at least one inflammation mediator antagonist.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.